Activation and Characterization of Lanthomicins A–C by Promoter Engineering in Streptomyces chattanoogensis L10

The emergence of drug resistance highlights the importance of new drug discovery. Microbial secondary metabolites encoded in biosynthetic gene clusters (BGCs) are a prolific source of drugs, whereas most of these BGCs are cryptic. Thus, taking strategies to activate these cryptic BGCs is of great importance for potential drug discovery. In this work, three novel pentangular polyphenols lanthomicin A–C were identified by activating a cryptic aromatic polyketide BGC through promoter engineering combined with optimization of fermentation conditions. We further confirmed the involvement of lanthomicin (ltm) BGC in biosynthesis by CRISPR-Cpf1-assisted gene editing. Based on functional analysis of homologous genes, a putative biosynthetic pathway was proposed for the three lanthomicins. Particularly, lanthomicin A showed antiproliferative activity with IC₅₀ 0.17 μM for lung cancer cell line A-549. The discovery of lanthomicins brings new members to the pentangular polyphenol subclade of aromatic polyketide and demonstrates the potential of Streptomyces as a source for drug discovery.

Introduction

Streptomyces genus has been one of the richest sources of bioactive natural products since the early 1950s (Baral et al., 2018). Indeed, a vast majority of compounds originating from this genus are clinically used in medicine, such as daptomycin (Vilhena and Bettencourt, 2012), doxorubicin (Arcamone et al., 1969), and FK506 (Rath, 2013). However, the drug discovery reached a bottleneck based on the classic bioactivity-guided approaches, while the drug resistance became a major threat to modern healthcare (Strachan and Davies, 2017). One promising approach to address this question comes with the development of genome sequencing technology. Genome mining of Streptomyces has revealed that they have far greater potential to produce specialized metabolites than have ever been estimated, based on the plethora of BGCs identified (Kalkreuter et al., 2020). Since it is by now well-established that most natural product BGCs are silent or poorly expressed under standard laboratory conditions that the cognate products do not accumulate to detectable levels (Nett et al., 2009). Therefore, the key question remaining to answer is how to access these hidden potentials.

In the light of huge sequence data in the genomic era, several main strategies have been developed in an attempt to harness this tremendous chemical diversity. These include promoter engineering (Li et al., 2017), diversification of culture conditions (Zhang et al., 2014), ribosome engineering (Wang et al., 2008; Thong et al., 2016), manipulation of regulators (Chen et al., 2017), and others. Among them, promoter engineering has been proved as a powerful and efficient method to activate or improve the biosynthesis of interest products (Li et al., 2015, 2017). Streptomyces chattanoogensis L10 is an industrial producing strain of natamycin, which is synthesized by type I polyketide synthases and widely used as an antifungal agent in both drug therapy and the food industry (Aparicio et al., 2016; Meena et al., 2021). Researchers have also activated the cryptic BGCs of chattamycins (Zhou et al., 2015) and anthrachamycin (Li et al., 2019) in S. chattanoogensis L10 by overexpressing regulatory gene and ribosome engineering, respectively. Both of them fell into the angucycline clade of aromatic polyketides. It seems that S. chattanoogensis L10 is inclined to produce polyketides, suggesting the potential to be developed as chassis for expressing exogenous BGCs (Bu et al., 2019).

In this study, we identified and activated a cryptic BGC of lanthomicin (ltm) by promoter engineering combined with optimization of fermentation conditions. Three newly synthesized lanthomicins were purified and their chemical structures were elucidated. We found that the lanthomicins represent new members of the pentangular polyphenols family. Cytotoxicity assay revealed that lanthomicin A possesses potential antiproliferative activity.

Materials and Methods

Strains and Media

The strain S. chattanoogensis L10 was used as a starting strain for genome mining. Escherichia coli DH5α was used as a general plasmid-cloning host. E. coli ET12567/pUZ8002 (Kieser et al., 2000) was used to introduce plasmids into Streptomyces by interspecies conjugation. S. chattanoogensis L10 and recombinant strains were grown at 30°C on YMG solid medium (yeast extract 0.4%, malt extract 1%, glucose 0.4%, agar 2%, and CaCO₃ 0.2%) for genetic screen and spore preparation (Supplementary Table 1). A total of 3% tryptic soy broth was used for vegetative growth of Streptomyces for genomic DNA extraction. MS solid medium (mannitol 2%, soybean flour 2%, and agar 2%) was used for exoconjugants growth. YEME liquid medium (yeast extract 0.3%, malt extract 0.3%, tryptone 0.5%, and glucose 4%) was used to produce lanthomicins. E. coli strains were cultured in a Luria-Bertani medium. When required, media were supplemented with antibiotics at the following final concentrations: chloramphenicol (25 μg/ml), nalidixic acid (25 μg/ml), and kanamycin (50 μg/ml). Spectinomycin was used in a final concentration of 50 μg/ml for E. coli, while 200 μg/ml for Streptomyces.

General DNA Manipulation

Polymerase chain reaction (PCR) was performed with KOD FX DNA polymerase (TOYOBO, Japan) for high-fidelity cloning and with rTaq DNA polymerase (Takara) for colony screening according to the instructions of the manufacturers. Gene fragments were purified by a gel extraction kit (Magen Biotech Co.) and plasmids were recovered from a plasmid extraction kit (Shanghai Generay Biotech Co.). DNA concentration was measured by a Nanodrop Lite spectrophotometer (Thermo Scientific Co.). Genomic DNA isolation of S. chattanoogensis L10 and its derivatives was performed as described (Kieser et al., 2000). Streptomyces colony PCR was also performed for rapid genotype validation: mycelium from single clones was scraped with a sterilized toothpick and ultrasonication in FTPS (10 mM Tris-HCl; 0.5 mM EDTA; and 0.1 mM KCl) solution, 1 μl of the solution was then used as a template for reactions.

Plasmid Construction

Primers used in this study were listed in Supplementary Table 3. Genomic DNA isolated from the L10 strain was used as a template for PCR amplification. The fidelity of amplified fragments was confirmed by DNA sequencing. pSET152 and pKC1139 were digested with SacI. The spectinomycin resistance gene was cloned by PCR with a primer pair spec-F/R using plasmid pIJ778 (Gust et al., 2003) as a template and then inserted into the above-digested vectors by seamless cloning, generating pSET152-spec and pKC1139-spec. For the purpose of constructing a universal vector to overexpress genes, pSET152-spec was digested with XbaI and EcoRV. A 97 bp PCR fragment of the kasO^* promoter amplified with primers kasO^*p-F/R was inserted into pSET152-spec, affording plasmid pSET152-spec-kasO^*. Detailed procedures for plasmid construction were described in Supplementary Methods. All the plasmids used in this work were listed in Supplementary Table 2.

High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS) Analysis

Fermentation broth of S. chattanoogensis L10 and recombinant strains from YEME were mixed with two volumes of methanol. After centrifugation for 5 min at 14,000 rpm (Eppendorf Centrifuge 5424R), the supernatant was filtered for high-performance liquid chromatography (HPLC) analysis, which was performed on an Agilent Liquid Chromatograph 1,260 (Agilent, Inc) equipped with a 4.6 × 150 mm Extend-C18 column, with a linear gradient of 5–100% MeCN-H₂O in 30 min followed by 100% MeCN for 5 min and 5% MeCN for another 5 min in a flow rate of 1 ml/min. LC-MS analysis was performed in an Agilent 1200 HPLC system (Agilent, Santa Clara, CA, USA) and a Termo Finnigan LCQDeca XP Max LC/MS system (Termo Finnigan, Waltham, MA, USA). Agilent Extend-C18 was used as the column, and H₂O (0.1% formic acid) and acetonitrile were used as the mobile phases A and B with a linear gradient from 5% to 100% (v/v) B over 30 min.

Cultivation, Extraction, and Isolation of Compounds

To accumulate enough compounds, L10 strains were cultivated in a 15 L fermenter at 30°C in YEME media for 7 days. When the fermentation was stopped, the fermentation broth was first adjusted pH to be lower than 4.0 with 2M hydrochloric acid solution and extracted three times using an equal volume of ethyl acetate. After removing the solvent in vacuo, the extract was fractioned by silica gel chromatography. Then, the fractions containing target compounds were subjected to Sephadex LH-20 column chromatography eluted with pure methanol. Purified extract was further refined by semipreparative liquid chromatography on an Agilent Eclipse XDB-C18 column (5 μm, 9.4 × 250 mm) using acetonitrile and 0.1% HCOOH (v/v) as eluent, yielding 5.4 mg of 1, 7 mg of 3, and 11.4 mg of 4.

Antiproliferative Assay

The cytotoxicity of lanthomicins A, B, and C was evaluated using the lung cancer cell line A-549, the breast carcinoma cell line MCF-7, the liver cancer cell line HepG2, and the colon carcinoma cell line HCT-116. HCT-116 cells were grown in McCoy's 5A Modified Medium (Gibco) supplemented with 10% fetal bovine serum (FBS). A-549, MCF-7, and HepG2 cells were grown in a DMEM medium (Gibco) supplemented with 10% FBS. Cells in log phase growth were harvested by trypsinization. Trypsinized cells were seeded onto 96-well plates (20,000 cells/ml) and incubated overnight at 37°C in the presence of 5% CO₂. Cells were transferred to a fresh medium supplemented with lanthomicins A–C (in dimethyl sulfoxide (DMSO)) in different final concentrations and incubated for 72 h to detect the cell viability using CCK8-based colorimetric assays. Doxorubicin was used as a positive control and DMSO was used as a negative control. Cell viability was recorded based on the percent stain present in each well relative to no drug DMSO control wells.

Results

Characterization of the Lanthomicin Gene Cluster From S. chattanoogensis L10

To get insight into the BGCs of S. chattanoogensis L10, we reanalyzed the completely sequenced genome (CGMCC 2644) using antiSMASH. It was found to possess 37 BGCs, namely, 8 polyketide synthases (PKSs), 2 nonribosomal peptide synthases (NRPSs), and one PKS-NRPS hybrid. A few terpene and lassopeptide BGCs were identified by the presence of corresponding synthase genes (Supplementary Table 4). Among the predicted BGCs, a type II PKS gene cluster (ltm, cluster 1) (Figure 1C) was shown to have about 50% homologies to known gene clusters of xan and arx, which are responsible for the biosynthesis of xantholipin and arixanthomycin, respectively (Zhang et al., 2012; Kang and Brady, 2014). Hence, we supposed the gene cluster ltm may be involved in the biosynthesis of pentangular polyphenols which belong to one subclade of the aromatic PKS family. Phylogenetic analysis also found that ketosynthase beta subunit (KS_β) LtmB from ltm gene cluster fell into the same subclade with a 26-carbon skeleton as that of xan and arx gene clusters (Figure 1B). The core skeleton of this subfamily was synthesized by minimal type II PKS (min-PKS), cyclases, and ketoreductases (KRs) in similar steps. Then the core structure was modified by various tailoring enzymes, which contributed to structural diversity. Examples of compounds from this subclade were listed in Figure 1A and distinctive structures were shown in color.

FIGURE 1

Figure 1. Comparative analysis of the lanthomicin biosynthetic gene cluster. (A) Examples of compounds belong to the pentangular polyphenol subfamily. (B) The maximum likelihood tree of LtmB with homologous KS_β proteins from the well-studied pentangular polyphenol clusters. These KS_β units could be divided into four groups according to the carbon chain length of their products. (C) ltm cluster was indicated by comparison with xan and arx clusters. The operons for promoter engineering were also indicated in the figure.

According to bioinformatic prediction, the ltm gene cluster consists of 34 genes (Table 1), including three FAD-dependent monooxygenases, among which LtmG3 showed considerable homology to XanO4 (70% identity) and Arx30 (64% identity). Phylogenetic analysis implied LtmG3 could be classified into an atypical Baeyer–Villiger monooxygenase branch (Supplementary Figure 1). LtmO, which strongly resembled the asparagine synthase homolog XanA (56% identity) and the amidotransferase homolog Arx5 (44% identity), also possessed five conserved amino acid sites for ligand binding and catalyzing (Supplementary Figure 2). Three methyltransferases were there, among them LtmMT2 showed the highest (68%) identity to XanM3 which directed the remethylation of C17 hydroxyl after a cryptic demethylation step catalyzed by XanO4 (Kong et al., 2016). Two cytochrome P450 oxidases LtmP1 and LtmP2 were found in the ltm cluster. Three enzymes, LtmD4, LtmD5, and LtmJ, whose exact functions were uncharacterized all distributed among these clusters.

TABLE 1

Table 1. Deduced functions of genes in the lanthomicin biosynthesis gene cluster and protein homologs annotation.

Activation of ltm by Promoter Knock-In and Variating Fermentation Environment

As Figure 1C shows, two pathway-specific regulatory genes are in the ltm cluster, a SARP family regulator-encoding gene ltmR1 and a TetR family regulator-encoding gene ltmR2. Usually, the TetR family regulators play a negative control in antibiotic biosynthesis, while SARP family regulators showed a positive role (Krause et al., 2020). Therefore, we attempted to overexpress the activator gene ltmR1 under the control of the strong promoter kasO*p and delete the repressor gene ltmR2 based on homologous recombination. The resulting recombinant strains L10-OE-R1 and L10-ΔR2 were cultivated for analysis of SMs as compared with starter strain L10. However, the metabolite profiles did not show any differential peaks (Figure 2C II and III), indicating that overexpression and/or deletion of the single regulatory gene was not sufficient to activate ltm cluster.

FIGURE 2

Figure 2. Activation of cryptic lanthomicin gene cluster by promoter knock-in and changing cultivating environment. (A) Lanthomicins were produced on a solid YMG plate by overexpression of ltmF1-D3 cassette. (B) Schematic of a promoter replacement strategy that a Km-kasO*p cassette was inserted upstream of the ltmF1 gene and replaced the native promoter by homologous recombination. (C) HPLC analysis of the metabolites from different strains (UV at 480 nm): (I) S. chattanoogensis L10; (II) S. chattanoogensis L10-OE-R1; (III) S. chattanoogensis L10-ΔR2; (IV) S. chattanoogensis L10-OE-F1D3; (V) S. chattanoogensis XF1; (VI) S. chattanoogensis XF1 (changing fermentation environment); (VII) isolated lanthomicin A; (VIII) isolated lanthomicin B; and (IX) isolated lanthomicin C.

To induce the expression of the ltm gene cluster, we further try to overexpress the core genes involved in polycyclic skeleton biosynthesis that would bypass the real regulatory pathway. The structural genes (ltmA-C), polyketide cyclase genes (ltmD1-D3), and a 3-oxoacyl-acyl carrier protein (ACP) reductase gene (ltmF1) seemed to be located in a single multicistron (Figure 1C), we cloned this multicistronic cassette (ltmF1-D3) into the integrative vector pSET152-spec-kasO^*, in which the strong promoter kasO^*p initiated their transcription. The resulting plasmid pXF03 was introduced into L10 to yield L10-OE-F1D3. As expected, overexpression of core gene cassette led to the production of brown pigments both on solid YMG plate and in liquid YEME media, suggesting the activation of gene cluster ltm successfully (Figure 2A; Supplementary Figure 3). Metabolites analysis of fermentation broth by HPLC showed that there are two new compounds produced in the overexpressed strain L10-OE-F1D3, lanthomicin A (1) and compound 2 (Figure 2C IV).

Inspired by the above results, we found that just downstream of the seven-gene multicistron, three monooxygenase genes (ltmE, ltmG1-G2), another one 3-oxoacyl-ACP reductase gene (ltmF2), and three genes (ltmH1-H3) serving the synthesis of malonyl-CoA extender unit, are arranged in the same direction as the ltmF1-D3 gene cassette (Figure 1C). We hypothesized that all these genes might be transcribed together to form a bigger transcript. So we replaced the native promoter with the strong promoter kasO^*p, which was inserted upstream of the ltmF1 gene by homologous recombination (Figure 2B). Finally, the generated strain S. chattanoogensis XF1 was confirmed by PCR (Supplementary Figure 4). The corresponding fermentation result revealed a new compound lanthomicin B (3) was synthesized (Figure 2C V). By changing the fermentation environment, we found that fermenting in a 15 L fermentor could produce several new homologs of 3 compared with a flask, and two of them displayed a distinct UV absorption spectrum (Figure 2C VI; Supplementary Figure 5). The difference in absorption spectra might imply structural change and we would like to identify the chemical alteration of lanthomicin C (4) with a higher yield. We also conducted the quantitative real-time PCR (qRT-PCR) experiment, the transcriptional levels of genes involved in the activated multicistron were significantly upregulated compared to the control strain L10, while genes distributed at two sides were almost the same transcriptional levels as the control strain (Figure 3).

FIGURE 3

Figure 3. Quantitative real-time PCR experiment. By promoter replacement, gene transcription levels from ltmF1 to ltmH3 in S. chattanoogensis XF1 were significantly upregulated, while genes distributed at two sides were almost the same transcriptional levels as the control strain L10. Fold change was indicated as log₂ (XF1/L10).

Confirmation of Lanthomicins Biosynthesis Gene Cluster ltm

Traditional genetic manipulation for S. chattanoogensis L10 was proved to be intricate and time-consuming (Liu et al., 2015). The CRISPR-Cpf1 system has been widely used in many bacterial species (Meliawati et al., 2021). In the genus Streptomyces, this system has been applied successfully to conduct precise genome editing by homology-directed repair (Li et al., 2018). To confirm that the ltm gene cluster is responsible for the biosynthesis of the three polyphenol lanthomicins, the functional domain of ltmA was used as the target for cleavage. First, the CRISPR-Cpf1 editing plasmid pKCCpf1 was introduced into S. chattanoogensis XF1. As Figure 4A shows, the transformation efficiency is very low and we suppose the expression level of Cpf1 is lethal to the host cell. So the inducible promoter tipAp was adopted to direct Cpf1 expression. When a gene-specific spacer was introduced into pKCCpf1(tipAp) to obtain pKCCpf1(tipAp)-ltmAspacer, the target position of ltmA in all exconjugants was destroyed, resulting in the abolishment of colored metabolites as compared with the strain XF1 containing pKCCpf1(tipAp) (Supplementary Figure 6). The addition of homologous arms (HAs) improved conjugation efficiency significantly and the successfully deleted colonies were found as expected (Figure 4A; Supplementary Figure 7). The metabolic profiles were performed to prove that lanthomicin B was not detected in the resulting strain S. chattanoogensis XF1-ΔA by HPLC analysis (Figure 4B II). For the complementation experiment, the ltmA gene was randomly inserted into the genome of mutant strain XF1-ΔA affording strain XF1-ΔA-OE-A, which restored the ability to produce lanthomicin B (Figure 4B III). These results suggested that the ltm gene cluster was involved in the biosynthesis of lanthomicins.

FIGURE 4

Figure 4. Confirmation of lanthomicins biosynthesis gene cluster ltm by the CRISPR-Cpf1-based gene-editing system. (A) Transformation efficiency was evaluated by counting the transformant number per 10⁶ viable spores. (B) HPLC analysis of lanthomicin B production from ltmA deletion and complement strains (UV at 480 nm): (I) S. chattanoogensis XF1; (II) S. chattanoogensis XF1-ΔA; (III) S. chattanoogensis XF1-ΔA-OE-A; and (IV) isolated lanthomicin B.

Isolation and Characterization of Lanthomicins

The structure of lanthomicins was elucidated based on NMR data (Supplementary Table 5; Supplementary Figures 13–33). Lanthomicin A (1) was obtained as murrey amorphous powder. The molecular formula was determined as C₂₅H₁₈O₉ on the basis of the anion peak at m/z 461.0879 [M-H]- by high-resolution mass spectrometry (HRMS). Careful comparison of the NMR data of 1 and metabolite 4, which has been activated and isolated from an engineered Streptomyces viridochromogenes strain in 2017 (Zhang et al., 2017), revealed that they share a similar dihydrobenzo[α] naphthacenequinone core. The only difference between them was that the methyl group at C-22 in metabolite 4 was replaced by the acetonyl group in 1. The acetonyl fragment was confirmed by the HMBC correlations from H3-25 (δ 2.17) to C-24 (δ 207.79) and C-23 (δ 53.32). The HMBC correlations from H2-23 (δ 2.68) to C-1 (δ 70.89), C-22 (δ 42.96), and C-2 (δ 52.17) revealed that the acetonyl moiety was attached to C-1. Hence, the structure of 1 was established (Figure 5). HRMS of compound 2 predicted a molecular formula C₂₆H₁₆O₁₀ with exact mass 487.0667 [M-H]-.

FIGURE 5

Figure 5. Planar structures of lanthomicin A-C. Key COSY, HMBC, and NOESY correlations of lanthomicin A–C are indicated.

Lanthomicin B (3) was obtained as a deep orange powder and its molecular formula was C₂₆H₁₈O₉ with an anion peak at 473.0876 [M-H]- based on the HRMS data. By literature searching, three main differences existed between 3 and hexaricin F (Gao et al., 2018), the substituents of C-6, C-11, and C-17 were -H, -OH, and -OH in 3 and -OH, -H, and -OCH₃ in hexaricin F, respectively. The structure was further confirmed by the new peak H-6 (δ 9.02, s) with correlations to C-5 (δ 141.18) and C-7 (δ 130.20), the disappearance of H-11, and the HMBC correlations from OH-17 (δ 12.51) to C-16 (δ 112.88) and C-18 (δ 131.89). Thus, the structure of 3 was established.

Lanthomicin C (4) was obtained as scarlet amorphous powder with molecular formula C₂₈H₂₂O₁₁ according to the anion peak at m/z 533.1087 [M-H]-. The COSY correlations of H-11 (7.30, d)/H-12 (7.34, d) indicated the difference in ring A between 3 and 4, and this was further confirmed by the HMBC correlations from HO-10 (δ 12.14) to C-9 (δ 113.42) and C-11 (δ 129.29). Another main COSY difference occurred in H-19 (δ 4.68)/H-20 (δ 3.51, 2.53), the lack of one hydrogen confirmed the oxhydryl introduced at C-19. And for 4, two extra molecules of methyl were linked by HMBC correlations from δ 3.41 to C-1 (δ 170.18) and C-25 (δ 106.72), from δ 3.89 to C-17 (δ 152.57). Henceforth, the structure of 4 was finished.

Antitumor Bioactivity of Lanthomicins

It has been reported that compounds synthesized by type II PKS often showed better inhibitory activity against tumor cell lines (Gan et al., 2015; Woo et al., 2016; Jiang et al., 2018). Therefore, we performed in vitro cytotoxicity assays for lanthomicins toward cancer cell lines using doxorubicin as a positive control. The results indicated that lanthomicin A showed antiproliferative activity toward lung cancer cell line A-549 with IC₅₀ 0.17 μM, while lanthomicin B and C demonstrated nonsignificant antiproliferative activity against all the cell lines (Table 2; Supplementary Figure 8).

TABLE 2

Table 2. Antitumor activity of lanthomicins.

Proposal of a Biosynthetic Pathway for Lanthomicins

The biosynthesis of the lanthomicins can be rationalized on the basis of successive activation of silent genes and functional analysis by homologous comparison. The key enzymes predicted to be involved in this process are shown in Figure 1C. The biosynthesis probably begins with condensing malonate units by the minimal type II PKSs LtmABC (Ketosynthase, KS_α; chain length factor or KS_β; ACP). Three enzymes LtmH1-H3 seem to be responsible for the biosynthesis of malonyl-CoA from the carboxylation of acetyl-CoA. Three KRs were found in ltm cluster and a phylogenetic analysis implied that LtmF1 might belong to C17 KRs, while LtmF2 was thus the likely C19 KR (Supplementary Figure 9). Thus LtmF1 was probably involved in the reduction of the keto group at C17 of the nascent polyketide chain to a hydroxyl group. The cyclases LtmD1-D3 were supposed to further modify the reduced skeleton directing the cyclization through intramolecular aldol condensations to form the angular 5-ring aromatic structure. Activation of the multicistronic cassette ltmF1D1D2ABCD3 could produce lanthomicin A and compound 2 (Figure 6 route 1). Three monooxygenases LtmE, LtmG1-G2, and a predicted C19 KR LtmF2 were also activated by promoter substitution and the fermentation profile changed leading to the discovery of lanthomicin B. LtmF2 was thus likely to catalyze the reduction of the 19-ketone to a hydroxyl group. We proposed that three monooxygenases might take responsibility for the closure of ring F in lanthomicin B. Lanthomicin C showed more methylation and hydroxylation than lanthomicin B. LtmF3, which was predicted as a C11 KR, thus might catalyze reduction in C11 carbonyl. LtmJ showed 55% identity to FdmM, which hydroxylated the C6 site during the biosynthesis of fredericamycin A (Chen et al., 2009), might also play a similar role during the biosynthesis (Figure 6 route 2).

FIGURE 6

Figure 6. The proposed biosynthetic pathway of lanthomicins.

Discussion

Secondary metabolites embedded in cryptic biosynthetic gene clusters (BGCs) with potential clinical value are well belongings of filamentous microorganisms, especially the genus Streptomyces. To activate cryptic clusters in S. chattanoogensis L10, we consider that natamycin is the main product of this strain and that blocking the main products in Streptomyces accelerates new compounds discovery (Culp et al., 2019). So we knocked out the first PKS gene in natamycin BGC to block its production, and we found that no new secondary metabolites were produced. We then used the natamycin-inactivated strain for activation. As mentioned above, 11 putative BGCs containing PKSs or NRPSs were found in the genome of S. chattanoogensis L10. Except for natamycin, chattamycin, and lanthomicin gene clusters, we also activated cluster 20 by a regulatory means. Recently, azoxymycins were found to be synthesized by linking two precursors with an azoxy bond (Guo et al., 2015) and how this unusual chemical connection could be formed was deeply interpreted (Guo et al., 2019). Several terpene and polypeptide BGCs were also found and bioactive polypeptide antibiotics could be identified by uncovering these cryptic pathways (Daniel-Ivad et al., 2017).

In this work, we found the ltm gene cluster with homology to xan and arx gene clusters, the corresponding natural products belong to the pentangular polyphenols subclade of aromatic PKS. The chemical diversity of this subclade is dependent on the postsynthetic modifications by some enzymes like methyltransferase and glycosyltransferase, especially some unknown oxygenases. It is worth mentioning that the pentangular polyphenols often display an inhibitory effect on tumor cells (Winter et al., 2013). To activate the cryptic ltm gene cluster, we adopt a combined strategy. We first overexpressed the putative positive regulator, disrupted the repressor gene, and combined the both. However, all these attempts failed to activate the gene cluster. Then we constitutively expressed the core gene cassette, resulting in the production of lanthomicin A and compound 2. The further knock-in of strong promoter kasO^*p in the upstream of ltmF1 along with changing fermentation environment ultimately led to the discovery of lanthomicin B and lanthomicin C. QRT-PCR showed that the transcriptional levels from ltmF1 to ltmH3 were strikingly improved and these genes seemed to be cotranscribed. Then, we successfully applied the CRISPR-Cpf1-based gene-editing tool to knock out the core skeleton gene ltmA in ltm gene cluster. The ltmA gene knockout and complement experiments further confirmed that the ltm gene cluster is responsible for the biosynthesis of the three polyphenol lanthomicins.

In this study, three novel pentangular polyphenols lanthomicin A–C were characterized by structure elucidation and antiproliferative activity evaluation. Lanthomicin A showed a characteristic in the E ring that the carboxyl group seemed to be lost and this situation was also found in the biosynthesis of pradimicin A (Zhan et al., 2008). Lanthomicin A also showed antiproliferative activity toward all of the tested cancer cell lines, with IC₅₀ values of 0.17 and 5.98 μM in A-549 and MCF-7 cells, respectively. Lanthomicin C showed more methylation and hydroxylation than others and reduction in C11 carbonyl was assumed to be catalyzed by the predicted C11 KR LtmF3 under a changed fermentation environment. There are no clues about which enzymes may be responsible for the formation of bonds at C5-C18 and C2-C23 (C1-C2 for lanthomicin A). Zhan and coworkers showed a monooxygenase PdmH worked collaboratively with two cyclases to form the 5-ring structure (Zhan et al., 2008). Hence, further studies were needed to uncover the cyclization in lanthomicin biosynthesis.

Data Availability Statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Author Contributions

X-FL: conceptualization, methodology, validation, investigation, data curation, formal analysis, visualization, writing—original draft, and writing—review and editing. J-XW: methodology, validation, and formal analysis. X-AC: formal analysis and writing—review and editing. YL: data curation and formal analysis. Y-QL: conceptualization, project administration, funding acquisition, supervision, and writing—review and editing. All authors read and approved the final manuscript.

Funding

This work was supported by the National Key Research and Development Program (Nos. 2018YFA0903200 and 2019YFA09005400) and the National Natural Science Foundation of China (Nos. 31730002 and 31520103901).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We thank Prof. Yin-Hua Lu, School of Life and Environmental Sciences, Shanghai Normal University, for providing the plasmid CRISPR-Cpf1.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2022.902990/full#supplementary-material

References

Aparicio, J. F., Barreales, E. G., Payero, T. D., Vicente, C. M., de Pedro, A., and Santos-Aberturas, J. (2016). Biotechnological production and application of the antibiotic pimaricin: biosynthesis and its regulation. Appl. Microbiol. Biotechnol. 100, 61–78. doi: 10.1007/s00253-015-7077-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C., et al. (1969). Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var caesius. Biotechnol. Bioeng. 11, 1101–1110. doi: 10.1002/bit.260110607

PubMed Abstract | CrossRef Full Text | Google Scholar

Baral, B., Akhgari, A., and Metsä-Ketel,ä, M. (2018). Activation of microbial secondary metabolic pathways: avenues and challenges. Synth. Syst. Biotechnol. 3, 163–178. doi: 10.1016/j.synbio.2018.09.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Bu, Q. T., Yu, P., Wang, J., Li, Z. Y., Chen, X. A., Mao, X. M., et al. (2019). Rational construction of genome-reduced and high-efficient industrial Streptomyces chassis based on multiple comparative genomic approaches. Microb. Cell. Fact. 18, 16. doi: 10.1186/s12934-019-1055-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, R. D., Zhang, Q. B., Tan, B., Zheng, L. J., Li, H. X., Zhu, Y. G., et al. (2017). Genome mining and activation of a silent PKS/NRPS gene cluster direct the production of totopotensamides. Org. Lett. 19, 5697–5700. doi: 10.1021/acs.orglett.7b02878

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, Y. H., Wendt-Pienkoski, E., Rajski, S. R., and Shen, B. (2009). In vivo investigation of the roles of FdmM and FdmM1 in fredericamycin biosynthesis unveiling a new family of oxygenases. J. Biol. Chem. 284, 24735–24743. doi: 10.1074/jbc.M109.014191

PubMed Abstract | CrossRef Full Text | Google Scholar

Culp, E. J., Yim, G., Waglechner, N., Wang, W., Pawlowski, A. C., and Wright, G. D. (2019). Hidden antibiotics in actinomycetes can be identified by inactivation of gene clusters for common antibiotics. Nat. Biotechnol. 37, 1149–1154. doi: 10.1038/s41587-019-0241-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Daniel-Ivad, M., Hameed, N., Tan, S., Dhanjal, R., Socko, D., Pak, P., et al. (2017). An engineered allele of afsQ1 facilitates the discovery and investigation of cryptic natural products. ACS. Chem. Biol. 12, 628–634. doi: 10.1021/acschembio.6b01002

PubMed Abstract | CrossRef Full Text | Google Scholar

Gan, M. L., Liu, B., Tan, Y., Wang, Q., Zhou, H. X., He, H. W., et al. (2015). Saccharothrixones A-D, tetracenomycin-type polyketides from the marine-derived actinomycete Saccharothrix sp. 10-10. J. Nat. Prod. 78, 2260–2265. doi: 10.1021/acs.jnatprod.5b00577

PubMed Abstract | CrossRef Full Text | Google Scholar

Gao, C. Z., Guo, Z. Y., Lu, X. Z., Chen, H. Y., Liu, L. W., Yu, Z. G., et al. (2018). Hexaricins, pradimicin-like polyketides from a marine sediment-derived Streptosporangium sp. and their antioxidant effects. J. Nat. Prod. 81, 2069–2074. doi: 10.1021/acs.jnatprod.8b00397

PubMed Abstract | CrossRef Full Text | Google Scholar

Guo, Y. Y., Li, H., Zhou, Z. X., Mao, X. M., Tang, Y., Chen, X., et al. (2015). Identification and biosynthetic characterization of natural aromatic azoxy products from Streptomyces chattanoogensis L10. Org. Lett. 17, 6114–6117. doi: 10.1021/acs.orglett.5b03137

PubMed Abstract | CrossRef Full Text | Google Scholar

Guo, Y. Y., Li, Z. H., Xia, T. Y., Du, Y. L., Mao, X. M., and Li, Y. Q. (2019). Molecular mechanism of azoxy bond formation for azoxymycins biosynthesis. Nat. Commun. 10, 4420. doi: 10.1038/s41467-019-12250-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Gust, B., Challis, G. L., Fowler, K., Kieser, T., and Chater, K. F. (2003). PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. Proc. Natl. Acad. Sci. 100, 1541–1546. doi: 10.1073/pnas.0337542100

PubMed Abstract | CrossRef Full Text | Google Scholar

Jiang, L., Pu, H., Xiang, J. X., Su, M., Yan, X. H., Yang, D., et al. (2018). Huanglongmycin A-C, cytotoxic polyketides biosynthesized by a putative type II polyketide synthase from Streptomyces sp. CB09001. Front. Chem. 6, 254. doi: 10.3389/fchem.2018.00254

PubMed Abstract | CrossRef Full Text | Google Scholar

Kalkreuter, E., Pan, G., Cepeda, A. J., and Shen, B. (2020). Targeting bacterial genomes for natural product discovery. Trends. Pharmacol. Sci. 41, 13–26. doi: 10.1016/j.tips.2019.11.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Kang, H. S., and Brady, S. F. (2014). Arixanthomycins A-C: Phylogeny-guided discovery of biologically active eDNA-derived pentangular polyphenols. ACS Chem. Biol. 9, 1267–1272. doi: 10.1021/cb500141b

PubMed Abstract | CrossRef Full Text | Google Scholar

Kieser, T., Bibb, M. J., Butter, M. J., Chater, K. F., and Hopwood, D. A. (2000). Practical Streptomyces Genetics. Norwich: The John Innes Foundation.

Kong, L. X., Zhang, W. K., Chooi, Y. H., Wang, L., Cao, B., Deng, Z. X., et al. (2016). A multifunctional monooxygenase XanO4 catalyzes xanthone formation in xantholipin biosynthesis via a cryptic demethoxylation. Cell. Chem. Biol. 23, 508–516. doi: 10.1016/j.chembiol.2016.03.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Krause, J., Handayani, I., Blin, K., Kulik, A., and Mast, Y. (2020). Disclosing the potential of the SARP-type regulator PapR2 for the activation of antibiotic gene clusters in Streptomycetes. Front. Microbiol. 11, 225. doi: 10.3389/fmicb.2020.00225

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, L., Wei, K. K., Zheng, G. S., Liu, X. C., Chen, S. X., Jiang, W. H., et al. (2018). CRISPR-Cpf1-assisted multiplex genome editing and transcriptional repression in Streptomyces. Appl. Environ. Microbiol. 84, e00827–e00818. doi: 10.1128/AEM.00827-18

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, S., Li, Y., Lu, C., Zhang, J., Zhu, J., Wang, H., et al. (2015). Activating a cryptic ansamycin biosynthetic gene cluster to produce three new naphthalenic octaketide ansamycins with n-pentyl and n-butyl side chains. Org. Lett. 17, 3706–3709. doi: 10.1021/acs.orglett.5b01686

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, S., Wu, X., Zhang, L., Shen, Y., and Du, L. (2017). Activation of a cryptic gene cluster in Lysobacter enzymogenes reveals a module/domain portable mechanism of nonribosomal peptide synthetases in the biosynthesis of pyrrolopyrazines. Org. Lett. 19, 5010–5013. doi: 10.1021/acs.orglett.7b01611

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, Z. Y., Bu, Q. T., Wang, J., Liu, Y., Chen, X. A., Mao, X. M., et al. (2019). Activation of anthrachamycin biosynthesis in Streptomyces chattanoogensis L10 by site-directed mutagenesis of rpoB. J. Zhejiang. Univ-Sci. B. 20, 983–994. doi: 10.1631/jzus.B1900344

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, S. P., Yuan, P. H., Wang, Y. Y., Liu, X. F., Zhou, Z. X., Bu, Q. T., et al. (2015). Generation of the natamycin analogs by gene engineering of natamycin biosynthetic genes in Streptomyces chattanoogensis L10. Microbiol. Res. 173, 25–33. doi: 10.1016/j.micres.2015.01.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Meena, M., Prajapati, P., Ravichandran, C., and Sehrawat, R. (2021). Natamycin: a natural preservative for food applications-a review. Food. Sci. Biotechnol. 30, 1481–1496. doi: 10.1007/s10068-021-00981-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Meliawati, M., Schilling, C., and Schmid, J. (2021). Recent advances of Cas12a applications in bacteria. Appl. Microbiol. Biotechnol. 105, 2981–2990. doi: 10.1007/s00253-021-11243-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Nett, M., Ikeda, H., and Moore, B. S. (2009). Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat. Prod. Rep. 26, 1362–1384. doi: 10.1039/b817069j

PubMed Abstract | CrossRef Full Text | Google Scholar

Rath, T. (2013). Tacrolimus in transplant rejection. Expert. Opin. Pharmacother. 14, 115–122. doi: 10.1517/14656566.2013.751374

PubMed Abstract | CrossRef Full Text | Google Scholar

Strachan, C. R., and Davies, J. (2017). The whys and wherefores of antibiotic resistance. Cold. Spring. Harb. Perspect. Med. 7, a025171. doi: 10.1101/cshperspect.a025171

PubMed Abstract | CrossRef Full Text | Google Scholar

Thong, W. L., Shin-ya, K., Nishiyama, M., and Kuzuyama, T. (2016). Methylbenzene-containing polyketides from a Streptomyces that spontaneously acquired rifampicin resistance: structural elucidation and biosynthesis. J. Nat. Prod. 79, 857–864. doi: 10.1021/acs.jnatprod.5b00922

PubMed Abstract | CrossRef Full Text | Google Scholar

Vilhena, C., and Bettencourt, A. (2012). Daptomycin: a review of properties, clinical use, drug delivery and resistance. Mini. Rev. Med. Chem. 12, 202–209. doi: 10.2174/1389557511209030202

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, G. J., Hosaka, T., and Ochi, K. (2008). Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations. Appl. Environ. Microbiol. 74, 2834–2840. doi: 10.1128/AEM.02800-07

PubMed Abstract | CrossRef Full Text | Google Scholar

Winter, D. K., Sloman, D. L., and Porco, J. A. Jr. (2013). Polycyclic xanthone natural products: structure, biological activity and chemical synthesis. Nat. Prod. Rep. 30, 382–391. doi: 10.1039/c3np20122h

PubMed Abstract | CrossRef Full Text | Google Scholar

Woo, C. M., Li, Z. W., Paulson, E. K., and Herzon, S. B. (2016). Structural basis for DNA cleavage by the potent antiproliferative agent (-)-lomaiviticin A. Proc. Natl. Acad. Sci. 113, 2851–2856. doi: 10.1073/pnas.1519846113

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhan, J. X., Watanabe, K. J., and Tang, Y. (2008). Synergistic actions of a monooxygenase and cyclases in aromatic polyketide biosynthesis. Chembiochem 9, 1710–1715. doi: 10.1002/cbic.200800178

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, M. M., Wong, F. T., Wang, Y. J., Luo, S. W., Lim, Y. H., Heng, E., et al. (2017). CRISPR-Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters. Nat. Chem. Biol. doi: 10.1038/nchembio.2341

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, W. J., Li, S. M., Zhu, Y. G., Chen, Y. C., Chen, Y. L., Zhang, H. B., et al. (2014). Heronamides D-F, polyketide macrolactams from the deep-sea-derived Streptomyces sp. SCSIO 03032. J. Nat. Prod. 77, 388–91. doi: 10.1021/np400665a

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, W. K., Wang, L., Kong, L. X., Wang, T., Chu, Y. W., Deng, Z. X., et al. (2012). Unveiling the post-PKS redox tailoring steps in biosynthesis of the type II polyketide antitumor antibiotic xantholipin. Cell. Chem. Biol. 19, 422–432. doi: 10.1016/j.chembiol.2012.01.016

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhou, Z. X., Xu, Q. Q., Bu, Q. T., Guo, Y. Y., Liu, S. P., Liu, Y., et al. (2015). Genome mining-directed activation of a silent angucycline biosynthetic gene cluster in Streptomyces chattanoogensis. ChemBioChem. 16, 496–502. doi: 10.1002/cbic.201402577

PubMed Abstract | CrossRef Full Text | Google Scholar